...
首页> 外文期刊>Trials >Electroacupuncture versus sham electroacupuncture for urinary retention in poststroke patients: study protocol for a multicenter, randomized controlled trial
【24h】

Electroacupuncture versus sham electroacupuncture for urinary retention in poststroke patients: study protocol for a multicenter, randomized controlled trial

机译:电针与假针刺治疗中风后尿retention留的研究:一项多中心,随机对照试验的研究方案

获取原文
           

摘要

Background This study protocol evaluates the effectiveness of adjuvant electroacupuncture (EA) for urinary retention in poststroke patients undergoing conventional treatments, in comparison with that of a sham control. Methods/design A multicenter, blinded, randomized controlled trial will be conducted in three hospitals in the Republic of Korea. We are recruiting 54 stroke survivors (aged >19?years), who were diagnosed with urinary retention based on the results of two consecutive post-void residual (PVR) tests, and dividing them randomly into two arms: the EA and Park-sham control groups. They will receive ten sessions of EA or sham treatment for 2?weeks. The participants will be blinded with non-penetrating needles and fake sounds of EA stimulators. The daily PVR ratio will be primarily measured at baseline and at the end of the study to statistically test the effectiveness of EA for poststroke urinary retention. Then, the Korean version of the Qualiveen Questionnaire, the Korean version of the International Prostate Symptom Score, and the blinding index will be assessed. After each EA session or sham EA, adverse events will be reported to evaluate the safety of EA. Results will be analyzed by using the independent t -test or Mann-Whitney U test, based on both intention-to-treat and per-protocol principles. Discussion The findings will provide clinical evidence for the effectiveness of EA treatment to improve urinary retention in stroke survivors. Trial Registration This study protocol was registered in ClinicalTrials.gov (NCT02472288) on 10 June 2015.
机译:背景本研究方案评估了与常规对照相比,在接受常规治疗的中风后患者中辅助电针(EA)对尿retention留的有效性。方法/设计将在大韩民国的三家医院进行一项多中心,随机,随机对照试验。我们正在招募54名卒中幸存者(年龄大于19岁),他们根据两次连续的无效尿后残留(PVR)测试的结果被诊断为尿retention留,并将他们随机分为两部分:EA和Park-sham对照组。他们将接受为期2周的十节EA或假治疗。参与者将被不刺穿的针头和EA刺激器的假声音蒙蔽。每日PVR比率将主要在基线和研究结束时进行测量,以统计测试EA对中风后尿retention留的有效性。然后,将评估韩文版的Qualiveen问卷,韩文版的国际前列腺症状评分和致盲指数。在每次EA会议或假EA之后,将报告不良事件以评估EA的安全性。将基于意图治疗和按方案原则,使用独立的t检验或Mann-Whitney U检验对结果进行分析。讨论该发现将为EA治疗改善卒中幸存者尿留的有效性提供临床证据。试验注册该研究方案已于2015年6月10日在ClinicalTrials.gov(NCT02472288)中进行了注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号